| 臺大學術典藏 |
2021-05-27T08:20:53Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; JYH-MING LIOU; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
JYH-MING LIOU; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:49Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
JYH-MING LIOU; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; JYH-MING LIOU; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2021-05-27T08:20:48Z |
Expressions of the CagA protein and CagA-signaling molecules predict Helicobacter pylori dependence of early-stage gastric DLBCL
|
Kuo S.-H.; Chen L.-T.; Lin C.-W.; Yeh K.-H.; Shun C.-T.; Tzeng Y.-S.; JYH-MING LIOU; Wu M.-S.; Hsu P.-N.; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
JYH-MING LIOU; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; JYH-MING LIOU; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:45Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
JYH-MING LIOU; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-05-27T08:20:41Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; Chen C.-C.; Tseng P.-H.; JYH-MING LIOU; Wu M.-S.; Shun C.-T.; Lee Y.-C.; Graham D.Y. |
| 臺大學術典藏 |
2021-05-27T08:09:49Z |
Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein
|
Cheng T.-Y.; Yang Y.-C.; Wang H.-P.; Tien Y.-W.; Shun C.-T.; Huang H.-Y.; Hsiao M.; KUO-TAI HUA |
| 臺大學術典藏 |
2021-05-27T02:50:21Z |
Helicobacter pylori infection and duodenal ulcer in children and adolescents.
|
Tsai C.J.; Chang M.H.; Tsai T.C.; Huang F.C.; JYH-CHIN YANG; Shun C.T. |
| 臺大學術典藏 |
2021-05-27T02:50:14Z |
Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice
|
JYH-CHIN YANG; Shun C.-T.; Chien C.-T.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:12Z |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication
|
JYH-CHIN YANG; Wang H.-L.; Chern H.-D.; Shun C.-T.; Lin B.-R.; Lin C.-J.; Wang T.-H. |
| 臺大學術典藏 |
2021-05-27T02:50:10Z |
Catechins and sialic acid attenuate helicobacter pylori -triggered epithelial caspase-1 activity and eradicate helicobacter pylori infection
|
JYH-CHIN YANG; Yang H.-C.; Shun C.-T.; Wang T.-H.; Chien C.-T.; Kao J.Y. |
| 臺大學術典藏 |
2021-05-27T02:50:08Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-05-26T09:08:31Z |
Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas
|
Hong R.-L.; Lee W.-J.; Shun C.-T.; Chu J.-S.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:25Z |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers
|
Yeh K.-H.; Chen C.-L.; Shun C.-T.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:24Z |
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:22Z |
Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy
|
Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; YAO-CHANG CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-05-26T09:08:14Z |
Isolation of multipotent cells from human term placenta
|
Yen B.L.; Huang H.-I.; Chien C.-C.; Jui H.-Y.; Ko B.-S.; Yao M.; Shun C.-T.; Yen M.-L.; Lee M.-C.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:05Z |
Analysis of cases of sexual assault presenting at a medical center in Taipei
|
Hwa H.-L.; Chen S.-C.; Wu M.-Z.; Shun C.-T.; Liu S.-K.; Lee J.C.-I.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:03Z |
Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs)
|
Yen M.-L.; Hou C.-H.; Peng K.-Y.; Tseng P.-C.; Jiang S.-S.; Shun C.-T.; YAO-CHANG CHEN; Kuo M.-L. |
| 臺大學術典藏 |
2021-05-26T03:35:50Z |
Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer
|
Yu C.-J.; Yang P.-C.; Shun C.-T.; Lee Y.-C.; Kuo S.-H.; KWEN-TAY LUH |
| 臺大學術典藏 |
2021-05-26T03:35:49Z |
Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer
|
Yu C.-J.; Shun C.-T.; Yang P.-C.; Lee Y.-C.; Shew J.-Y.; Kuo S.-H.; KWEN-TAY LUH |
| 臺大學術典藏 |
2021-05-26T03:35:40Z |
Quantitative analysis of mRNA encoding MUC1, MUC2, and MUC5AC genes: A correlation between specific mucin gene expression and sialomucin expression in non-small cell lung cancer
|
Yu C.-J.; Shew J.-Y.; Shun C.-T.; Lin H.-T.; Kuo S.-H.; KWEN-TAY LUH; Yang P.-C. |
